ArticleTranslational gastroenterology and hepatology2018
Utility and performance characteristics of a novel submucosal injection agent (Eleview
Article in Translational gastroenterology and hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Review on colorectal endoscopic submucosal dissection focusing on the technical aspect.Surgical endoscopy · 2020Pooled it
- SAFETY AND EFFECTIVENESS OF BLUE EYE HYPERTONIC SOLUTION VERSUS SALINE SOLUTION IN THE TREATMENT OF FLAT COLONIC LESIONS: A RANDOMIZED CLINICAL TRIAL.Arquivos de gastroenterologia · 2026Trial
- Randomized controlled trial investigating use of submucosal injection of EverLift™ in rates of complete resection of non-pedunculated 4-9 mm polyps.International journal of colorectal disease · 2022Trial
- Submucosal injection-related foreign body reaction complicating endoscopic submucosal dissection: this time, it is not the usual suspect.iGIE : innovation, investigation and insights · 2026Article
- Sodium Alginate-Based Submucosal Lifting Hydrogel for Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.Advanced healthcare materials · 2026Article
- Technical Advances in Endoscopic Resection Techniques for Lower GI Malignancies.Visceral medicine · 2024Review
- Lifting agent granuloma presenting as a colonic mass mimicking cancer: a report of three cases.AME case reports · 2023Article
- Use of a novel dual-action clip for closure of complex endoscopic resection defects.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2022Article
- In Vitro and In Vivo Investigation on the Effectiveness of Alginate-Based Gastric Mucosal Protective Gel.BioMed research international · 2022Article
- ESD and Pit Pattern Diagnosis: Lessons from a Japanese Endoscopist Working in the United States.Clinics in colon and rectal surgery · 2020Review
- Efficacy and Safety of a Novel Submucosal Injection Solution for Resection of Gastrointestinal Lesions.Journal of clinical medicine · 2020Article
- Evaluation of EleviewPolymers · 2020Article
- An internal magnet traction device reduces procedure time for endoscopic submucosal dissection by expert and non-expert endoscopists: ex vivo study in a porcine colorectal model (with video).Surgical endoscopy · 2019Article
- Novel technique for endoscopicWorld journal of gastroenterology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubmucosal injection of a lifting agent is a critical step in endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). Literature suggests superiority of other viscous solutions over normal saline (NS), but research to determine the ideal submucosal injection is still ongoing. In this prospective cohort study, we evaluated the utility and performance characteristics of a novel submucosal injection agent (Eleview
methodsTwelve consecutive patients referred for EMR/ESD to a tertiary referral center with experienced large polyp expert were prospectively enrolled. Ten patients with large colon polyps (mean age 66.3 years), and one patient each with esophageal and gastric lesions were included. Eleview
resultsSingle injection of 3-5 cc of Eleview
conclusionsEleview
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.